CBRE vs MRKR · P/E 43, rev $21.75B vs rev $751.7K
CBRE Group Inc Class A (CBRE) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. MRKR currently screens at market cap $25.3M.
Not investment advice. Open the CBRE and MRKR stock pages for the full models.
Not investment advice.